.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AE09_Tipranavir.Tipranavir

Information

Tipranavir is a non-peptidic protease inhibitor used in combination with ritonavir for the treatment of HIV-1 infection in treatment-experienced adult patients. It is approved for use in several countries, but its use has declined in favor of other newer antiretrovirals.

Pharmacokinetics

Population pharmacokinetic analysis in HIV-infected adults, administered orally with ritonavir boosting.

References

1. (2006). Tipranavir: PNU 140690, tipranivir. Drugs in R&D 7(1) 55–62. DOI:10.2165/00126839-200607010-00005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16620137

Revisions

• 06/2025 initial generated model